354 related articles for article (PubMed ID: 33405021)
1. The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune Cells.
Wu YJ; Wang L; Ji CF; Gu SF; Yin Q; Zuo J
Inflammation; 2021 Jun; 44(3):821-834. PubMed ID: 33405021
[TBL] [Abstract][Full Text] [Related]
2. The Effect of α7nAChR Signaling on T Cells and Macrophages and Their Clinical Implication in the Treatment of Rheumatic Diseases.
Pan S; Wu YJ; Zhang SS; Cheng XP; Olatunji OJ; Yin Q; Zuo J
Neurochem Res; 2022 Mar; 47(3):531-544. PubMed ID: 34783974
[TBL] [Abstract][Full Text] [Related]
3. α7 nicotinic acetylcholine receptor signaling modulates the inflammatory phenotype of fetal brain microglia: first evidence of interference by iron homeostasis.
Cortes M; Cao M; Liu HL; Moore CS; Durosier LD; Burns P; Fecteau G; Desrochers A; Barreiro LB; Antel JP; Frasch MG
Sci Rep; 2017 Sep; 7(1):10645. PubMed ID: 28878260
[TBL] [Abstract][Full Text] [Related]
4. 3-Dehydroandrographolide protects against lipopolysaccharide-induced inflammation through the cholinergic anti-inflammatory pathway.
Lu Z; Xie P; Zhang D; Sun P; Yang H; Ye J; Cao H; Huo C; Zhou H; Chen Y; Ye W; Yu L; Liu J
Biochem Pharmacol; 2018 Dec; 158():305-317. PubMed ID: 30391477
[TBL] [Abstract][Full Text] [Related]
5. The role of the cholinergic anti-inflammatory pathway in septic cardiomyopathy.
Wang W; Xu H; Lin H; Molnar M; Ren H
Int Immunopharmacol; 2021 Jan; 90():107160. PubMed ID: 33243604
[TBL] [Abstract][Full Text] [Related]
6. Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: Role of α7 nicotinic acetylcholine receptors.
Keever KR; Yakubenko VP; Hoover DB
Pharmacol Res; 2023 May; 191():106758. PubMed ID: 37028776
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic signaling via the α7 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation.
Keever KR; Cui K; Casteel JL; Singh S; Hoover DB; Williams DL; Pavlov VA; Yakubenko VP
J Neuroinflammation; 2024 Jan; 21(1):3. PubMed ID: 38178134
[TBL] [Abstract][Full Text] [Related]
8. Activation of cholinergic anti-inflammatory pathway involved in therapeutic actions of α-mangostin on lipopolysaccharide-induced acute lung injury in rats.
Yang Z; Yin Q; Olatunji OJ; Li Y; Pan S; Wang DD; Zuo J
Int J Immunopathol Pharmacol; 2020; 34():2058738420954941. PubMed ID: 32886564
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
10. The Protective Effect of Alpha 7 Nicotinic Acetylcholine Receptor Activation on Critical Illness and Its Mechanism.
Ren C; Tong YL; Li JC; Lu ZQ; Yao YM
Int J Biol Sci; 2017; 13(1):46-56. PubMed ID: 28123345
[TBL] [Abstract][Full Text] [Related]
11. Role of the α7 Nicotinic Acetylcholine Receptor and RIC-3 in the Cholinergic Anti-inflammatory Pathway.
Treinin M; Papke RL; Nizri E; Ben-David Y; Mizrachi T; Brenner T
Cent Nerv Syst Agents Med Chem; 2017; 17(2):90-99. PubMed ID: 27573666
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of alpha 7 nicotinic acetylcholine receptor (α7nAChR) inhibits atherosclerosis via immunomodulatory effects on myeloid cells.
Ulleryd MA; Mjörnstedt F; Panagaki D; Yang LJ; Engevall K; Gutiérrez S; Wang Y; Gan LM; Nilsson H; Michaëlsson E; Johansson ME
Atherosclerosis; 2019 Aug; 287():122-133. PubMed ID: 31260875
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.
Xie H; Yepuri N; Meng Q; Dhawan R; Leech CA; Chepurny OG; Holz GG; Cooney RN
Rev Endocr Metab Disord; 2020 Dec; 21(4):431-447. PubMed ID: 32851581
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic anti-inflammatory pathway inhibits neointimal hyperplasia by suppressing inflammation and oxidative stress.
Li DJ; Fu H; Tong J; Li YH; Qu LF; Wang P; Shen FM
Redox Biol; 2018 May; 15():22-33. PubMed ID: 29197233
[TBL] [Abstract][Full Text] [Related]
15. The role of alpha7 nicotinic acetylcholine receptors in inflammatory bowel disease: involvement of different cellular pathways.
Seyedabadi M; Rahimian R; Ghia JE
Expert Opin Ther Targets; 2018 Feb; 22(2):161-176. PubMed ID: 29298542
[TBL] [Abstract][Full Text] [Related]
16. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion.
Zhao M; He X; Bi XY; Yu XJ; Gil Wier W; Zang WJ
Basic Res Cardiol; 2013 May; 108(3):345. PubMed ID: 23519622
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic modulation of the immune system presents new approaches for treating inflammation.
Hoover DB
Pharmacol Ther; 2017 Nov; 179():1-16. PubMed ID: 28529069
[TBL] [Abstract][Full Text] [Related]
18. The effects of dexmedetomidine pretreatment on the pro- and anti-inflammation systems after spinal cord injury in rats.
Rong H; Zhao Z; Feng J; Lei Y; Wu H; Sun R; Zhang Z; Hou B; Zhang W; Sun Y; Gu X; Ma Z; Liu Y
Brain Behav Immun; 2017 Aug; 64():195-207. PubMed ID: 28302458
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Xiang H; Hu B; Li Z; Li J
Inflammation; 2014 Oct; 37(5):1763-70. PubMed ID: 24803295
[TBL] [Abstract][Full Text] [Related]
20. Activation of α7 nicotinic acetylcholine receptors attenuates monocyte-endothelial adhesion through FUT7 inhibition.
Wu CH; Inoue T; Nakamura Y; Uni R; Hasegawa S; Maekawa H; Sugahara M; Wada Y; Tanaka T; Nangaku M; Inagi R
Biochem Biophys Res Commun; 2022 Jan; 590():89-96. PubMed ID: 34973535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
